You are here: Home About Us Board of Visitors

Board of Visitors

Joseph T. Abdalla '89, MBA
General Manager
Commercial StrategyGroup
United BioSource Corporation

George Abercrombie '78, MBA

Paul J. Atkins, PhD
Chief Executive Officer
Oriel Therapeutics

James W. Crow
United Therapeutics, Inc.
Founder, President, and Chief Operating Officer (Retired)

Marty DeBerardinis, PhD ‘82
Director, Medicines Evaluation–Infection US/UK
R&D Pharmaceutical Development
AstraZeneca Pharmaceuticals LP

Fred Eshelman '72, PharmD
Executive Chairman
Pharmaceutical Product Development

Neal Fowler '84, MBA '88
CEO
Liquidia Technologies

Joe Graedon, MS
President
Graedon Enterprises, Inc.
The People’s Pharmacy

Mark Gregory
Vice President of Pharmacy and Government Relations
Kerr Drug, Inc.

Reg Hardy ’81, MBA

Jimmy Jackson
Spoke Consulting, Inc.

M. Ross Johnson, PhD
President and CEO
Parion Sciences, Inc.

Bryant Mangum '74
Vice President Pharmacy Services
Premier, Inc.

Bruce McWhinney, PharmD
Bernard Consulting Group

Douglas W. Mendenhall, PhD
dwm Consulting, LLC

David S. Moody '73
CEO
Mutual Drug Company

William “Whit” Moose '60
Past President, NCPA
Moose Drug Company

Louis A. Newsome '77
UnitedHealthcare of North Carolina
Pharmacy Account Executive, Mid-Atlantic Region

Frank Press
Huron Consulting Group

Ron H. Small '66, MBA
Vice President, Quality Outcomes
Interim VP/CIO Informatics
Chief Pharmacy Officer
NC Baptist Hospital
Wake Forest University Baptist Medical Center

Catherine C. Stokes, MS '86
President and CEO
Drug Safety Alliance, Inc.

Chris L. Waller, PhD '92
Senior Director, HealthCare Informatics
Medical Business Technology
Pfizer



Document Actions